Co-Trimoxazole Paediatric Suspension is indicated in children aged 12 years and under (infants (>6 weeks to <2 years old) and children (>2 to <12 years old) for the treatment of the following infections when owing to sensitive organisms (see section 5.1): • Treatment and prevention of Pneumocystis jirovecii pneumonitis (PJP). • Treatment and prophylaxis of toxoplasmosis. • Treatment of nocardiosis. The following infections may be treated with Co-Trimoxazole where there is bacterial evidence of sensitivity to Co-Trimoxazole and good reason to prefer the combination of antibiotics in Co-Trimoxazole to a single antibiotic: • Acute uncomplicated urinary tract infection. • Acute otitis media. • Acute exacerbation of chronic bronchitis. Consideration should be given to official guidance on the appropriate use of antibacterial agents.